期刊文献+

血清25(OH)D水平与痴呆发病风险的剂量—反应Meta分析

A dose-response meta-analysis of serum 25(OH)D levels and the risk of dementia
下载PDF
导出
摘要 目的系统分析血清25羟基维生素D[25(OH)D]与痴呆发病风险的剂量—反应关系。方法检索中国学术期刊全文数据库(CNKI)、万方数据知识服务平台、PubMed、Embase、Cochrane Library、Web of Science数据库中研究血清25(OH)D与痴呆发病风险的剂量—反应关系的相关文献,检索时限从数据库创建到2021年9月,采用Stata 16.0软件使用广义最小二乘估计方法(GLST)分析血清25(OH)D与痴呆发病风险的剂量—反应关系。结果共纳入9篇文献,含11项研究,包括42054例研究对象,其中发生痴呆3480例。基于随机效应模型对各原始研究最高剂量组相对于最低剂量组的RR值及95%CI进行合并,Meta分析结果显示,血清25(OH)D水平与痴呆发病风险呈负相关[RR(95%CI)=0.751(0.615~0.916),P=0.005]。剂量—反应Meta分析显示,随着血清维生素D水平升高,痴呆发病风险逐渐降低;血清维生素D水平每增加1 nmol/L,痴呆发病风险降低0.3%(OR=0.997,95%CI 0.996~0.999,P<0.001),血清维生素D水平与痴呆发病风险相关,且可能存在线性负相关(RR=-0.003,P<0.001)。结论血清25(OH)D水平与痴呆发病风险呈线性负相关。 Objective To systematic analysis of the dose-response relationship between serum 25(OH)D and the risk of dementia.Methods Relevant literatures on the dose-response relationship between serum 25(OH)D and the risk of dementia were searched in CNKI,Wanfang Data Knowledge Service Platform,PubMed,Embase,Cochrane Library,and Web of Science databases.The time frame was from database creation to September 2021,and Stata 16.0 software was used to analyze the dose-response relationship between serum 25(OH)D and the risk of dementia using generalized least squares estimation method(GLST).Results A total of 9 articles were included,including 11 studies,including 42054 subjects,of which 3480 had dementia.Based on the random effects model,the RR values and 95%CI of the highest dose group relative to the lowest dose group in each original study were combined.Meta-analysis results showed that serum 25(OH)D levels were negatively correlated with the risk of dementia[RR(95%)CI)=0.751(0.615-0.916),P=0.005].The dose-response Meta-analysis showed that with the increase of serum vitamin D level,the risk of dementia gradually decreased;for every 1 nmol/L increase of serum vitamin D level,the risk of dementia decreased by 0.3%(OR=0.997,95%CI 0.996-0.999),P<0.001),serum vitamin D level was associated with the risk of dementia,and there may be a linear negative correlation(RR=-0.003,P<0.001).Conclusion Serum 25(OH)D levels were linearly inversely related to the risk of dementia.
作者 周巧 汤瑶 罗兴梅 Zhou Qiao;Tang Yao;Luo Xing-mei(Guizhou Medical University,Guizhou Province,Guiyang 550000,China)
出处 《疑难病杂志》 CAS 2022年第3期297-301,共5页 Chinese Journal of Difficult and Complicated Cases
基金 贵州省卫生健康委科学技术基金项目(gzwjkj2020-1-019)。
关键词 痴呆 25-羟基维生素D 阿尔茨海默病 剂量—反应关系 META分析 Dementia 25 hydroxyvitamin D Alzheimer’s disease Dose-response relationship Meta analysis
  • 相关文献

参考文献2

二级参考文献14

  • 1Grimes DA,Schulz KF.An overview of clinical research:the lay of the land[J].Lancet,2002,359(9300):57-61.
  • 2Egger M,Smith GD,Altman DG.Systematic reviews in health care.Meta-analysis in context[M].2nd ed.London:BMJ Publishing Group,BMA House,Tavistock Square,WC1H 9JR,2001.
  • 3Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses[J].Eur J Epidemiol,2010,25(9):603-5.
  • 4Wells GA,Shea B,O'Connell D,et al.The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in metaanalyses[EB/OL].[2012-06-15].http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
  • 5Wells G,Shea B,O'Connell D,et al.NewCastle-Ottawa Quality Assessment Scale --Cohort Studies[EB/OL].[2012-06-15].http:// www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • 6Wells G,Shea B,O'Connell D,et al.NewCastle–Ottawa Quallty Assessment Scale--Case Control Studies[EB/OL].[2012-06-15].http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • 7Ibbotson T,Grimshaw J,Grant A.Evaluation of a programme of workshops for promoting the teaching of critical appraisal skills[J].Med Educ,1998,32(5):486-91.
  • 8CASP(Critical Skills Appraisal Programme)[EB/OL].[2012-06-15].http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_Cohort_Appraisal_Checklist_14oct10.pdf.
  • 9CASP(Critical Skills Appraisal Programme)[EB/OL].[2012-06-15].http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_Case-Control_Appraisal_Checklist_14oct10.pdf.
  • 10Rostom A,Dube C,Cranney A,et al.Celiac Disease.Rockville (MD):Agency for Healthcare Research and Quality (US); 2004 Sep.(Evidence Reports/Technology Assessments,No.104.) Appendix D.Quality Assessment Forms.http://www.ncbi.nlm.nih.gov/books/NBK35156.

共引文献1001

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部